These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
512 related items for PubMed ID: 27599598
21. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists. Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P. Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371 [Abstract] [Full Text] [Related]
22. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids. You-Ning L, Humphries M, Du X, Wang L, Jiang J. Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199 [Abstract] [Full Text] [Related]
23. Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma. Bergmann KC, Lindemann L, Braun R, Steinkamp G. Swiss Med Wkly; 2004 Jan 24; 134(3-4):50-8. PubMed ID: 14745658 [Abstract] [Full Text] [Related]
24. The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel multidose dry powder inhaler in adolescents and adults with persistent asthma. Nugent C, Yiu G, Song S, Caracta C. J Asthma; 2018 Aug 24; 55(8):898-906. PubMed ID: 28933971 [Abstract] [Full Text] [Related]
25. Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA. Bernstein D, Andersen L, Forth R, Jacques L, Yates L. J Asthma; 2018 Sep 24; 55(9):984-993. PubMed ID: 28961020 [Abstract] [Full Text] [Related]
26. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW. J Allergy Clin Immunol; 1998 Jul 24; 102(1):32-8. PubMed ID: 9679845 [Abstract] [Full Text] [Related]
27. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S. Clin Ther; 2008 Aug 24; 30(8):1492-504. PubMed ID: 18803991 [Abstract] [Full Text] [Related]
28. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma. Medley H, Orozco S, Allen A. Clin Ther; 2012 Aug 24; 34(8):1683-95. PubMed ID: 22796247 [Abstract] [Full Text] [Related]
29. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety. Bodzenta-Lukaszyk A, Buhl R, Balint B, Lomax M, Spooner K, Dissanayake S. J Asthma; 2012 Dec 24; 49(10):1060-70. PubMed ID: 23102189 [Abstract] [Full Text] [Related]
30. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah T. Chest; 2003 Sep 24; 124(3):834-43. PubMed ID: 12970006 [Abstract] [Full Text] [Related]
32. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma. Kupryś-Lipińska I, Tworek D, Vanderbist F, Bocheńska-Marciniak M, Kuna P. Pneumonol Alergol Pol; 2013 Sep 24; 81(6):527-36. PubMed ID: 24142782 [Abstract] [Full Text] [Related]
36. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T. J Allergy Clin Immunol; 2000 Jun 24; 105(6 Pt 1):1108-16. PubMed ID: 10856143 [Abstract] [Full Text] [Related]
37. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T. Ann Allergy Asthma Immunol; 1999 Mar 24; 82(3):257-65. PubMed ID: 10094216 [Abstract] [Full Text] [Related]
39. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma. ZuWallack R, Adelglass J, Clifford DP, Duke SP, Wire PD, Faris M, Harding SM. Chest; 2000 Aug 24; 118(2):303-12. PubMed ID: 10936117 [Abstract] [Full Text] [Related]
40. Comparative pulmonary function and pharmacokinetics of fluticasone propionate and salmeterol xinafoate delivered by two dry powder inhalers to patients with asthma. Harrison LI, Novak CC, Needham MJ, Ratner P. J Aerosol Med Pulm Drug Deliv; 2011 Oct 24; 24(5):245-52. PubMed ID: 21671752 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]